Functional diversity increases the efficacy of phage combinations. (2021)
Attributed to:
Does CRISPR-Cas immunity limit the effectiveness of phage therapy?
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1099/mic.0.001110
PubMed Identifier: 34850676
Publication URI: http://europepmc.org/abstract/MED/34850676
Type: Journal Article/Review
Volume: 167
Parent Publication: Microbiology (Reading, England)
Issue: 12
ISSN: 1350-0872